IVsight as an Infusion Monitor for Patients Receiving Intravenous Therapy: An Exploratory, Unblinded, Single-Center Trial

IF 1.6 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Carlos Mejia-Chew MD , Brett Heuring PharmD , Jeffrey Salmons RN , Lori Weilmuenster PharmD , Joe Beggs BEng , Glen Kleinschmidt BEng , Jake Eshelman BEng , Sai Dodda PharmD
{"title":"IVsight as an Infusion Monitor for Patients Receiving Intravenous Therapy: An Exploratory, Unblinded, Single-Center Trial","authors":"Carlos Mejia-Chew MD ,&nbsp;Brett Heuring PharmD ,&nbsp;Jeffrey Salmons RN ,&nbsp;Lori Weilmuenster PharmD ,&nbsp;Joe Beggs BEng ,&nbsp;Glen Kleinschmidt BEng ,&nbsp;Jake Eshelman BEng ,&nbsp;Sai Dodda PharmD","doi":"10.1016/j.curtheres.2024.100747","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Intravenous (IV) infusion therapy is commonly used in health care settings. However, IV therapy at home can be challenging because it relies on the patient's ability to manage multiple medications correctly, which may lead to decreased treatment adherence.</p></div><div><h3>Objective</h3><p>We aimed to assess the usability and accuracy of the IVsight monitor in capturing IV infusion data compared to manual recording.</p></div><div><h3>Methods</h3><p>A prospective, single-center, usability study involving patients receiving IV infusion therapy at one of the BJC's Home Infusion suites was conducted to evaluate the accuracy, performance, and acceptability of the device IVsight as a monitor for IV infusions.</p></div><div><h3>Results</h3><p>Of the 15 participants, the median (IQR) age was 46 years (36–55), 8 (53%) were female, and 13 (87%) were non-Hispanic white. Each participant received a median (IQR) of 4 (4–5) infusions during the study, and 68 infusions were observed overall. The intraclass correlation coefficient between the IVsight measurement and manual recording of infusion duration in seconds was excellent (ICC 0.97, 95% confidence interval 0.96–0.98). The Bland–Altman plot visually showed an acceptable limit of agreement for the 2 measurements, and the linear regression analysis revealed no significant proportional bias between the 2 methods for measuring the IV infusion time. None of the participants thought that IVsight was difficult to hold, use, clean, or store. Only one participant was concerned that the device could interfere with the IV infusion, and all participants felt comfortable with the device transmitting data to their health care providers.</p></div><div><h3>Conclusions</h3><p>The IVsight infusion monitoring device showed near-perfect agreement on the recorded IV infusion duration compared with manual recording, and good acceptability among the study participants.</p></div>","PeriodicalId":10920,"journal":{"name":"Current Therapeutic Research-clinical and Experimental","volume":"100 ","pages":"Article 100747"},"PeriodicalIF":1.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0011393X24000171/pdfft?md5=80fd87cb1f8920d6b08acb8349f56587&pid=1-s2.0-S0011393X24000171-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Therapeutic Research-clinical and Experimental","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0011393X24000171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Intravenous (IV) infusion therapy is commonly used in health care settings. However, IV therapy at home can be challenging because it relies on the patient's ability to manage multiple medications correctly, which may lead to decreased treatment adherence.

Objective

We aimed to assess the usability and accuracy of the IVsight monitor in capturing IV infusion data compared to manual recording.

Methods

A prospective, single-center, usability study involving patients receiving IV infusion therapy at one of the BJC's Home Infusion suites was conducted to evaluate the accuracy, performance, and acceptability of the device IVsight as a monitor for IV infusions.

Results

Of the 15 participants, the median (IQR) age was 46 years (36–55), 8 (53%) were female, and 13 (87%) were non-Hispanic white. Each participant received a median (IQR) of 4 (4–5) infusions during the study, and 68 infusions were observed overall. The intraclass correlation coefficient between the IVsight measurement and manual recording of infusion duration in seconds was excellent (ICC 0.97, 95% confidence interval 0.96–0.98). The Bland–Altman plot visually showed an acceptable limit of agreement for the 2 measurements, and the linear regression analysis revealed no significant proportional bias between the 2 methods for measuring the IV infusion time. None of the participants thought that IVsight was difficult to hold, use, clean, or store. Only one participant was concerned that the device could interfere with the IV infusion, and all participants felt comfortable with the device transmitting data to their health care providers.

Conclusions

The IVsight infusion monitoring device showed near-perfect agreement on the recorded IV infusion duration compared with manual recording, and good acceptability among the study participants.

将 CloudConnect 作为静脉注射疗法患者的输液监控器:一项探索性、非盲法、单中心试验。
背景静脉(IV)输液疗法是医疗机构的常用疗法。然而,在家中进行静脉输液治疗可能具有挑战性,因为它依赖于患者正确管理多种药物的能力,这可能会导致治疗依从性下降。目的我们旨在评估 IVsight 监测器在采集静脉输液数据时与手动记录相比的可用性和准确性。方法 我们对在北京和睦家医院家庭输液室接受静脉输液治疗的患者进行了一项前瞻性、单中心、可用性研究,以评估 IVsight 设备作为静脉输液监控器的准确性、性能和可接受性。结果 在 15 名参与者中,年龄中位数(IQR)为 46 岁(36-55),8 名(53%)为女性,13 名(87%)为非西班牙裔白人。每位参与者在研究期间接受的输液次数中位数(IQR)为 4 次(4-5 次),共观察到 68 次输液。IVsight 测量与人工记录输液持续时间(秒)之间的类内相关系数非常好(ICC 0.97,95% 置信区间 0.96-0.98)。布兰-阿尔特曼图直观地显示出两种测量方法的一致性达到了可接受的范围,线性回归分析表明两种测量静脉输液时间的方法之间没有明显的比例偏差。没有一位参与者认为 IVsight 难以握持、使用、清洁或储存。结论与手动记录相比,IVsight 输液监测设备记录的静脉输液时间几乎完全一致,研究参与者的接受度也很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
31
审稿时长
3 months
期刊介绍: We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics. CTR encourages and supports the submission of manuscripts describing: • Interventions designed to understand or improve human health, disease treatment or disease prevention; • Studies that focus on problems that are uncommon in resource-rich countries; • Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing); • Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English; • Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信